Newsroom | 67824 results

Sorted by: Latest

General Health
-

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib met its primary endpoint of non-inferiority compared to Ocrevus® (ocrelizumab) in reducing disability progression in patients with primary progressive multiple sclerosis (PPMS). Fenebrutinib showed a 12% reduction in the risk of...
-

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson announced 12-month pilot-phase data from the OMNY-AF study and highlighted new findings related to the VARIPULSE Platform....
-

ŌURA Named Official Wearable of Team USA and LA28 Olympic and Paralympic Games

SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, maker of the world’s leading smart ring, Oura Ring, today announced a strategic partnership as the Official Wearable of Team USA and the LA28 Olympic & Paralympic Games. As Team USA and LA28’s exclusive provider in the category of continuous health and fitness tracking devices, ŌURA will support U.S. Olympic and Paralympic athletes from both the 2026 and 2028 Games and will provide them with an Oura Ring to help manage their athletic performance, recove...
-

Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems (collectively, the “Products”) distributed in the United States, United Kingdom, Mexico, Australia, and the Caribbean. Trividia is updating the E-5 Error Code in the “Messages” section of...
-

OnMed Named 2026 Impact Product of the Year by Impact One Awards

NEW YORK--(BUSINESS WIRE)--OnMed Named 2026 Impact Product of the Year by Impact One Awards...
-

TRUBAR Acquired by ETi Gıda for $173 Million, Ushering in Next Phase of Global Growth

MIAMI--(BUSINESS WIRE)--TRUBAR, the fast-growing protein bar brand known for its dessert-inspired flavors and clean ingredients, today announced the completion of its acquisition by ETi Gıda, a leading global snack company headquartered in Turkey (Türkiye). Under the terms of the agreement, ETi Gıda acquired 100% of TRUBAR for $173 million in cash, with no earn-out. The acquisition marks a pivotal moment in TRUBAR’s growth trajectory, positioning the brand to scale further across North America...
-

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced that the Company’s board of directors (the “Board”) has approved the voluntary delisting of the Company’s common stock from The Nasdaq Capital Market (“Nasdaq”) and the subsequent voluntary deregistration of its common stock with the U.S. Securi...
-

Afya Limited Announces Medical Seats Increase in Afya Abaetetuba

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and provider of medical practice solutions in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) has authorized an increase of 63 medical seats for ITPAC – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. (“Afya Abaetetuba”), located in the city of Abaetetuba, in t...
-

EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities

BOSTON--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, in collaboration with President Trump’s administration, announced new patient access pathways to make its complete portfolio of infertility medications used for in vitro fertilization (IVF), including Gonal-f® (follitropin alfa for injection), Ovidrel® (choriogonadotropin alfa injection), and Cetrotide® (cetrorelix acetate for injection), more accessible to prescribed infertili...
-

A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program

HOUSTON--(BUSINESS WIRE)--The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children’s lives through this access-to-oral-health-care initiative. What began as a local grassroots movement in St. Louis, MO, has evolved into a national movement, having served more than 10.2 million underserved children since 2003. GKAS begins nationally in February, which is National C...